Associated Papers
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma.
Yen I et al.
Nature, 2021
Frequent and Rare HABP2 Variants Are Not Associated with Increased Susceptibility to Familial Nonmedullary Thyroid Carcinoma in the Spanish Population.
de Randamie R et al.
Hormone Research in Paediatrics, 2018
Select a paper to view details